Bionor Pharma ASA Will Conduct Further Trials of HIV Vaccine After Early Test Failure

Bloomberg -- Bionor Pharma ASA is proceeding with development of its experimental HIV vaccine even after it failed to keep patients off antiviral drugs in an early trial.